RCCPS 2010 Features
Stephen B.H. Kent
University of Chicago
Peptides for Pleasure and for Profit
Kunwar Shailubhai
Synergy Pharmaceuticals
Guanylate Cyclase-C Agonists as a New Class of Drug Candidates for GI disorders and Inflammatory Bowel Disease
Tom Tice
SurModics, Inc.
The Role Of Peptide Properties During Microencapsulation And Extended-Release From Bioresorbable Polymers”
John Howl
University of Wolverhampton, U.K.
Targeted Delivery of Bioactive Cell Penetrating Peptides: Implications for Anti-cancer Therapy.
Rob Liskamp
Utrecht University
Peptides on synthetic scaffolds for mimicry of proteins towards synthetic vaccines and beyond
Join us for the
Roche Colorado Corporation Peptide Symposium 2010
September 14 - 16
St. Julien Hotel and Spa
Boulder, Colorado
Who should attend?
RCCPS seeks to bring together key decision leaders from both industry and academia to discuss the future of peptide therapeutics. Even though peptide therapeutics are potent and highly selective, their development into effective treatments can be challenged by limited delivery routes, product stability, manufacturing challenges and an evolving regulatory landscape. RCCPS is the key forum where these challenges will be identified, discussed, and one day—addressed.
| Event Calender | |
| Sept 14 | Opening Reception Peptide Showcase Presentations by Early Stage Companies on Peptide Therapeutics and Enabling Technologies |
| Sept 15 | Keynote Address Peptides in the Clinic Drug Delivery and Formulation Gala Dinner at the Red Lion Inn Meienhofer Award Presentation |
| Sept 16 | Cell Penetrating Peptides and Tissue Targeting Advances in Chemistry and Analytics Poster Session Networking Reception |
More Information
To REGISTER click here
To find out about SPONSORSHIP click here
To present at STARTUP SHOWCASE click here
To submit a POSTER click here
| GOLD SPONSORS | |||
 |
 |
 |
 |